Minnesota’s psychedelic medicine taskforce published their first major report on Wednesday, including their recommendations on the use of psychedelic drugs like psylocibin, MDMA and LSD for medical purposes.
The taskforce has tapped into a growing body of research that suggests that these psychedelic drugs could be a game changer in the field of psychotherapy to treat conditions like addiction, PTSD, depression and bipolar disorder.
Tags: New Drug Trend Psilocybin